Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia in Nepalese men often starts around age 29, with a possible link to COVID-19 worsening the condition.

Altered hormones and insulin resistance are common in young men with early hair loss and linked to more severe cases.

Receding hairlines in men are uneven, with the right side larger than the left.

Androgenetic alopecia, or hair loss, is influenced by hormones and genetics, and can be treated with medications like minoxidil, finasteride, or hormone therapy, with effectiveness evaluated after 6 months.

Hair loss in young men linked to higher risk of insulin resistance and metabolic issues.

Advanced male pattern baldness affects the back of the scalp, reducing hair follicles.

There's no link between hair loss type androgenic alopecia and benign prostatic hyperplasia, but early hair loss and family history can mean more severe alopecia.

High incidence of hair loss found in COVID-19 patients, but no severity correlation established.

A boy with GAPO syndrome had hair loss similar to male pattern baldness without hormone issues, possibly due to skin or blood vessel problems.

Using a laser with minoxidil was more effective for hair loss than minoxidil alone.

Higher sebum levels are linked to more severe male baldness.

Platelet rich plasma treatment is effective for hair loss in both men and women.

Platelet-rich plasma injections effectively treat hair loss in both men and women, increasing hair density with high patient satisfaction and no significant side effects.

Androgenetic alopecia may increase the severity of COVID-19.

More severe hair loss worsens quality of life in men.

Minoxidil alone is the most cost-effective treatment for male hair loss at a $50,000 threshold.

Men with early baldness have similar heart risk factors as others, but certain proteins are linked to higher heart disease risk.

No link found between hair loss severity and PSA levels in men.

No link between hair loss severity and PSA levels in men.

Early-onset male baldness is not linked to insulin resistance, but is significantly associated with metabolic syndrome.

PRP is effective in treating male pattern baldness.

Scalp reduction can improve hair distribution in certain baldness cases but requires careful patient selection and understanding of facial structure.

There is no link between hair loss and prostate enlargement.

A man with a new type of male pattern hair loss that affects the back of the head responded well to common hair loss treatments.

Microneedling combined with minoxidil is more effective and safe for hair growth in men with hair loss.

The research found no clear link between the severity of male baldness and the scalp examination findings in Indonesian men.

Finasteride reduces hair follicle cell death in androgenetic alopecia.

PRP treatment showed no hair regrowth improvement after the first application in patients with alopecia.

More men have androgenic alopecia than women, with stress linked to the condition in both genders.

The BASP classification is more reliable than the Norwood-Hamilton for classifying hair loss in men and women.